A detailed history of Harbor Group, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Harbor Group, Inc. holds 1,865 shares of ABT stock, worth $193,997. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,865
Previous 1,955 4.6%
Holding current value
$193,997
Previous $215,000 1.86%
% of portfolio
0.06%
Previous 0.06%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

SELL
$109.52 - $120.96 $9,856 - $10,886
-90 Reduced 4.6%
1,865 $211,000
Q4 2023

Jan 10, 2024

BUY
$90.19 - $110.4 $176,321 - $215,832
1,955 New
1,955 $215,000
Q2 2023

Jul 13, 2023

BUY
$100.78 - $112.29 $197,024 - $219,526
1,955 New
1,955 $213,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Harbor Group, Inc. Portfolio

Follow Harbor Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbor Group, Inc. with notifications on news.